New study predicts changing Lyme disease habitat across the West Coast
Army of ‘citizen scientists’ collect more than 18,000 tick samples for analysis in study funded by Bay Area Lyme Foundation
FLAGSTAFF, Ariz. — March 16, 2021 — The findings of a recent analysis conducted by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that ecosystems suitable for harboring ticks that carry debilitating Lyme disease could be more widespread than previously thought in California, Oregon and Washington.
Bolstering the research were the efforts of an army of “citizen scientists” who collected and submitted 18,881 ticks over nearly three years through the Free Tick Testing Program created by the Bay Area Lyme Foundation, which funded the research, producing a wealth of data for scientists to analyze.
This new study builds on initial research led by the late Nate Nieto, Ph.D., at Northern Arizona University, and Daniel Salkeld, Ph.D., of Colorado State University.
This immense sample collection represented a multi-fold increase in the number of ticks that could be gathered by professional biologists conducting field surveys in far less time and at a fraction of the cost. This kind of citizen participation — which in the future could include smart-phone apps and photography — could become “a powerful tool” for tracking other animal- and insect-borne infectious diseases important for monitoring human and environmental health, according to study results published in the scientific journal PLOS ONE.
This study expands on previous work in California and is the first study to produce high resolution distributions of both actual and potential tick habitat in Oregon and Washington.
“This study is a great example of how citizen scientists can help — whether tracking climate change, fires, habitat changes or species distribution shifts — at a much finer scale than ever before,” said Tanner Porter, Ph.D., a TGen Research Associate and lead author of the study.
Specifically, Dr. Porter said the findings of this study could help raise awareness among physicians across the West, and throughout the nation, that tick-borne diseases are possible throughout a wider expanse than ever thought before.
Lyme disease is caused by a bacteria, Borrelia burgdorferi (sensu lato), which is carried by ticks, and in this study specifically, the western black-legged tick known as Ixodes pacificus. These ticks also carry pathogens associated with relapsing fever and anaplasmosis, which like Lyme disease can cause fever, headache, chills and muscle aches. Some patients with Lyme disease may experience a rash that may look like a red oval or bull’s-eye.
If not treated promptly, Lyme disease can progress to a debilitating stage, becoming difficult and sometimes impossible to cure. This may include inflammation of the heart and brain.
Lyme disease is the most common tickborne illness in the U.S., annually causing an estimated 500,000 infections, according to the CDC. However, even the most commonly-used diagnostic test for Lyme disease misses up to 70% of early stage cases. There is no treatment that works for all patients.
“We hope this study data encourages residents of California, Oregon and Washington to take precautions against ticks in the outdoors, and helps to ensure that local healthcare professionals will consider diagnoses of Lyme when patients present with symptoms,” said Linda Giampa, Executive Director of the Bay Area Lyme Foundation.
Citizen scientists were encouraged to mail in ticks collected off individuals’ bodies, pets and clothing. They noted the time and place where the ticks were discovered, and described activities involved, the surrounding environment, and in many cases specific GPS coordinates.
Field studies could take decades to produce the same amount of data, said Dr. Porter, adding, “this citizen science technique could allow for real-time distribution monitoring of ticks and other relevant species, an important consideration with emerging pathogens, changing land-use patterns, and climate change.”
This study builds on TGen’s “One Health Collaborative,” an initiative that uses a holistic approach to monitor the health of humans, animals and the environment, according to David Engelthaler, Ph.D., head of TGen’s infectious disease studies.
The study — Predicting the current and future distribution of the western black-legged tick, Ixodes pacificus, across the Western US using citizen science collections — was published Jan. 5 In PLOS ONE.
About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: CityofHope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
TGen Senior Science Writer